OCEAN study: The first randomized controlled study to compare octreotide treatment with standard of care in patients with angiodysplasia-related bleeding @Joostphdrenth Lia @LucasBernts ow.ly/IPx050R8Nk8

'Hub & Spoke' model is a pathway for urgent #plasmaexchange for rodenticide ingestion induced #liverfailure in #TamilNadu #India. This model could be replicable in low-resource settings for saving people with acute liver failure of diverse aetiologies bit.ly/440y3Of

Hyperfine Swoop low-field portable MRI scanner procured recently, making CMC Vellore #first hospital in the country to have this state-of-the-art, AI-powered scanner; magnetic field of only 0.064 T, making it safer & more energy-efficient than traditional MRI scanners. #radiology

Was fortunate to be a part of this wonderful initiative - SHARP 2024. Thank you so much for this opportunity Arun Sanyal Saul Karpen Ajay Duseja INASL and Dr. Abhijit. Look forward to working together Arun Valsan Arka De Santhosh E Kumar Rohit Mehtani

Dear public , This message is for recent havoc created regarding “Covishield Vaccine” stating that it causes Blood clots (thrombosis) and reduced platelets (thrombocytopenia) Let’s clear some facts : • There is not a single vaccine/drug ever produced which doesnt have any

Many Congress handles are spreading a misleading narrative that COVID-19 vaccination was more harmful than not taking it. Please be aware that many studies have established the net benefits of this vaccine. The AstraZeneca news doing the rounds doesn't change that. #Covishield

Happy to share our narrative review on #AcuteLiverFailure in #pregnancy Indian Journal of Gastroenterology link.springer.com/article/10.100…

#livertwitter #gitwitter #plasmaexchangeforLiver IndianApheresis alex

From The Hindu Dated June 10, 2024. Low cost MRI machine uses 0.05 T magnets and doesn’t need a shielded room or helium coolant to operate. Deep learning algorithms for resolution correction.Can be plugged into standard wall-power outlets. #livertwitter

Thrilled to share our latest publication - Predictors of outcome in rodenticidal hepatotoxicity patients managed with low volume plasma exchange #plasmaexchanage #acuteliverfailure #rodenticide pubmed.ncbi.nlm.nih.gov/39001974/ Indian Journal of Gastroenterology Santhosh E Kumar Ajay Duseja Saul Karpen

pubmed.ncbi.nlm.nih.gov/39181168/ 💥 Recompensation in 24.7% 24.7% of 1152 HCV related cirrhosis patients following SVR-12, portal hypertension progressed in 13.7% and 2.9% had a new development of HCC over 48 months follow-up. Data from Punjab, India 🇮🇳 Radha K Dhiman

Original Article Predictors of long-term clinical outcomes after TIPS: An ALTA group study Nobel et al. ​​#LiverX tinyurl.com/2snewywf

I glance down at the paperwork my patient has filled out before his visit. Occupation: Retired harbour master. Two things: I’ve never met a harbor master before. And “harbour” with a “u.” Interesting. It’s the little everyday mysteries that I love most. That reveal us. 1/

#KLM2024 Kolkata Liver Meeting takes off with Prof Sanyal Arun J. Sanyal speaking on Metabolic Health, Prof Wedemeyer Heiner Wedemeyer on Viral hepatitis, Dr Asisha Asisha Janeela on liver health priorities and Prof Jalan Prof Rajiv Jalan talking on reducing deaths in cirrhosis.

To shorten or not to shorten vasoactive agents after endoscopy....That is the question (We try to address in this IPMA!) doi.org/10.1007/s10620… Shalimar Vishal Sharma Yujun_Wong Manas Vaishnav Shubham Mehta EASLnews The Baveno Cooperation: an EASL Consortium AASLD Liver Fellow Network Journal of Gastroenterology and Hepatology

Collaborative Study EASLnews 🇦🇹AT🇩🇰DE🇮🇹IT researchers have shown that the prognosis of #Patients wtih #Cirrhosis #Complications depends on the pattern of #acute (AD) or #nonacute (NAD) #Decompensation Aleksander Krag MedUni Wien et al. onlinelibrary.wiley.com/doi/full/10.11…

Anytime a patient is referred to me with decompensated cirrhosis for transplant evaluation, I ask myself: is it possible to recompensate it by treating the cause so a transplant can be avoided? All you need to know about this: Nature Reviews Gastroenterology & Hepatology 👉 thelancet.com/journals/langa…

A must-read review in the NEJM on the most common cause of chronic liver disease: MASLD. All you need to know: trends, pathogenesis, early detection, co-morbidities, lifestyle changes and novel and future drugs….. shorturl.at/N88Ed